Efficacy and safety of Shengjiang Xiexin decoction on irinotecan-induced diarrhea in small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial

Efficacy and safety of Shengjiang Xiexin decoction on irinotecan-induced diarrhea in small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial

Abstract Background Irinotecan is a standard chemotherapeutic agent in small cell lung cancer (SCLC), however, as a common adverse reaction, diarrhea limits the use of irinotecan. Shengjiang Xiexin decoction (SXD) has been used in various gastrointestinal diseases in China two thousand years ago. We...

Full description

Saved in:
Bibliographic Details
Main Authors: Chao Deng, Qing Liu, Meng Yang, Hui-juan Cui, Yang Ge, Qin Li, Shi-jie Zhu, Guo-wang Yang, Zhi-guo Zhang, Yu Gao, Yan-ni Lou, Li-qun Jia
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Chinese Medicine
Subjects:
Irinotecan-induced diarrhea
Randomized controlled trial
Shengjiang Xiexin decoction
Online Access:https://doi.org/10.1186/s13020-024-01025-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13020-024-01025-6

Similar Items